{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:10:37Z","timestamp":1792800637259,"version":"4.5.0"},"reference-count":292,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Central Nervous System Drug Key Laboratory of Sichuan Province","award":["240024-01SZ"],"award-info":[{"award-number":["240024-01SZ"]}]},{"name":"The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People's Government and Southwest Medical University","award":["2024LZXNYDJ089"],"award-info":[{"award-number":["2024LZXNYDJ089"]}]},{"name":"Luzhou Municipal Science and Technology Bureau","award":["2024JYJ079"],"award-info":[{"award-number":["2024JYJ079"]}],"id":[{"id":"https:\/\/ror.org\/04kxx2q73","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02434-3","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:01:59Z","timestamp":1758805319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance"],"prefix":"10.1186","volume":"24","author":[{"given":"Fei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"3","key":"2434_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"2434_CR2","first-page":"149","volume-title":"Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients","author":"S Das","year":"2023","unstructured":"Das S, et al. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients, vol. 40. London, England: Medical Oncology (Northwood; 2023. p. 149."},{"key":"2434_CR3","doi-asserted-by":"crossref","unstructured":"Glackin CA. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer. Enzymes. 2018;44:83\u2013101.","DOI":"10.1016\/bs.enz.2018.08.004"},{"key":"2434_CR4","first-page":"1927","volume":"9","author":"AG Sacco","year":"2016","unstructured":"Sacco AG, Worden FP. Molecularly targeted therapy for the treatment of head and neck cancer: a review of the erbb family inhibitors. OncoTargets Therapy. 2016;9:1927\u201343.","journal-title":"OncoTargets Therapy"},{"key":"2434_CR5","doi-asserted-by":"publisher","first-page":"102701","DOI":"10.1016\/j.ctrv.2024.102701","volume":"125","author":"M Bartoletti","year":"2024","unstructured":"Bartoletti M, et al. Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis. Cancer Treat Rev. 2024;125:102701.","journal-title":"Cancer Treat Rev"},{"issue":"10286","key":"2434_CR6","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, et al. Breast cancer. Lancet (London England). 2021;397(10286):1750\u201369.","journal-title":"Lancet (London England)"},{"key":"2434_CR7","doi-asserted-by":"crossref","unstructured":"Palaskas NL et al. Cardiovascular toxicity of immune therapies for cancer. BMJ (Clinical research ed.), 2024. 385: p. e075859.","DOI":"10.1136\/bmj-2023-075859"},{"issue":"7971","key":"2434_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","volume":"619","author":"DJ Baker","year":"2023","unstructured":"Baker DJ, et al. CAR T therapy beyond cancer: the evolution of a living drug. Nature. 2023;619(7971):707\u201315.","journal-title":"Nature"},{"key":"2434_CR9","volume-title":"Targeting programmed cell death as an innovative strategy against atherosclerosis: potential of natural compound supplements","author":"J Fan","year":"2025","unstructured":"Fan J, et al. Targeting programmed cell death as an innovative strategy against atherosclerosis: potential of natural compound supplements. Phytotherapy Research: PTR; 2025."},{"issue":"1","key":"2434_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Therapy. 2022;7(1):286.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"2434_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer. 2022;21(1):32.","journal-title":"Mol Cancer"},{"issue":"1","key":"2434_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and Cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2434_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"key":"2434_CR14","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2024;72:101018.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"key":"2434_CR15","first-page":"1254","volume-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Volume 375. New York, N.Y.): Science; 2022. pp. 1254\u201361. 6586."},{"issue":"5","key":"2434_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting Cuproplasia and Cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21(5):370\u201388.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2434_CR17","doi-asserted-by":"publisher","first-page":"e70484","DOI":"10.1096\/fj.202500047R","volume":"39","author":"Q Zou","year":"2025","unstructured":"Zou Q, et al. Cuproptosis inhibits tumor progression and enhances cisplatin toxicity in ovarian cancer. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2025;39(6):e70484.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"2434_CR18","doi-asserted-by":"crossref","unstructured":"Jin Y, et al. Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting Cuproptosis through the Akt pathway. Volume 179. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2024. p. 117415.","DOI":"10.1016\/j.biopha.2024.117415"},{"key":"2434_CR19","doi-asserted-by":"crossref","unstructured":"Yang Z et al. Hypoxia inducible factor-1\u03b1 drives cancer resistance to Cuproptosis. Cancer Cell, 2025.","DOI":"10.1016\/j.ccell.2025.02.015"},{"issue":"1","key":"2434_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12920-023-01511-0","volume":"16","author":"D Zhang","year":"2023","unstructured":"Zhang D, et al. Comprehensive analysis of a cuproptosis-related CeRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer. BMC Med Genom. 2023;16(1):96.","journal-title":"BMC Med Genom"},{"key":"2434_CR21","doi-asserted-by":"crossref","unstructured":"Li P, et al. Combination of the cuproptosis inducer disulfiram and anti PD L1 abolishes NSCLC resistance by ATP7B to regulate the HIF 1 signaling pathway. Int J Mol Med. 2024;53(2):19.","DOI":"10.3892\/ijmm.2023.5343"},{"key":"2434_CR22","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves AC et al. Impact of cancer metabolism on therapy resistance - Clin implications. Drug Resistance Updates: Reviews and Commentaries In Antimicrobial and Anticancer Chemotherapy, 2021. 59: p. 100797.","DOI":"10.1016\/j.drup.2021.100797"},{"issue":"1","key":"2434_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/NRR.NRR-D-24-00696","volume":"21","author":"Y Sun","year":"2026","unstructured":"Sun Y, et al. Potential mechanisms of non-coding RNA regulation in alzheimer\u2019s disease. Neural Regeneration Res. 2026;21(1):265\u201380.","journal-title":"Neural Regeneration Res"},{"key":"2434_CR24","doi-asserted-by":"crossref","unstructured":"Jia H, et al. Trans-Kingdom RNA Dialogues: miRNA and milRNA Networks as Biotechnological Tools for Sustainable Crop Defense and Pathogen Control. Plants (Basel). 2025;14(8):1250.","DOI":"10.3390\/plants14081250"},{"key":"2434_CR25","doi-asserted-by":"crossref","unstructured":"Ye R, et al. New insights into long non-coding RNAs in non-small cell lung cancer. Biomed Pharmacother. 2020;131:110775.","DOI":"10.1016\/j.biopha.2020.110775"},{"issue":"1","key":"2434_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-024-02074-z","volume":"23","author":"D Fei","year":"2024","unstructured":"Fei D, et al. Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway. Mol Cancer. 2024;23(1):159.","journal-title":"Mol Cancer"},{"key":"2434_CR27","doi-asserted-by":"publisher","first-page":"107780","DOI":"10.1016\/j.compbiomed.2023.107780","volume":"169","author":"Y Luo","year":"2024","unstructured":"Luo Y, Liu L, Zhang C. Identification and analysis of diverse cell death patterns in diabetic kidney disease using microarray-based transcriptome profiling and single-nucleus RNA sequencing. Comput Biol Med. 2024;169:107780.","journal-title":"Comput Biol Med"},{"key":"2434_CR28","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, et al. Identification of cuproptosis-related LncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198.","journal-title":"Comput Biol Med"},{"issue":"1","key":"2434_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41065-024-00311-5","volume":"161","author":"S Liang","year":"2024","unstructured":"Liang S, et al. Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma. Hereditas. 2024;161(1):10.","journal-title":"Hereditas"},{"key":"2434_CR30","doi-asserted-by":"publisher","first-page":"1549294","DOI":"10.3389\/fcell.2024.1549294","volume":"12","author":"Z Chai","year":"2024","unstructured":"Chai Z, Yuan Z, Chen Y. Stem cell status and prognostic applications of cuproptosis-associated LncRNAs in acute myeloid leukemia. Front Cell Dev Biology. 2024;12:1549294.","journal-title":"Front Cell Dev Biology"},{"issue":"12","key":"2434_CR31","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.7150\/ijbs.98806","volume":"20","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, et al. Elucidating the evolving role of Cuproptosis in breast cancer progression. Int J Biol Sci. 2024;20(12):4872\u201387.","journal-title":"Int J Biol Sci"},{"key":"2434_CR32","doi-asserted-by":"publisher","first-page":"110324","DOI":"10.1016\/j.abb.2025.110324","volume":"765","author":"NE El-Ashmawy","year":"2025","unstructured":"El-Ashmawy NE, et al. Cuproptosis regulation by long noncoding rnas: mechanistic insights and clinical implications in cancer. Arch Biochem Biophys. 2025;765:110324.","journal-title":"Arch Biochem Biophys"},{"key":"2434_CR33","doi-asserted-by":"publisher","first-page":"1097075","DOI":"10.3389\/fimmu.2023.1097075","volume":"14","author":"D Lu","year":"2023","unstructured":"Lu D, et al. Construction and systematic evaluation of a machine learning-based cuproptosis-related LncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma. Front Immunol. 2023;14:1097075.","journal-title":"Front Immunol"},{"issue":"1","key":"2434_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin P, et al. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol. 2022;15(1):97.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"2434_CR35","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708\u201328.","journal-title":"Cell"},{"issue":"1","key":"2434_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23(1):261.","journal-title":"Mol Cancer"},{"key":"2434_CR37","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy. Volume 21. Human Vaccines & Immunotherapeutics; 2025. p. 2459458. 1.","DOI":"10.1080\/21645515.2025.2459458"},{"key":"2434_CR38","doi-asserted-by":"publisher","first-page":"217846","DOI":"10.1016\/j.canlet.2025.217846","volume":"627","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, et al. Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis. Cancer Lett. 2025;627:217846.","journal-title":"Cancer Lett"},{"issue":"30","key":"2434_CR39","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1200\/JCO.23.02641","volume":"42","author":"EN Bergstrom","year":"2024","unstructured":"Bergstrom EN, et al. Deep learning artificial intelligence predicts homologous recombination deficiency and platinum response from histologic slides. J Clin Oncology: Official J Am Soc Clin Oncol. 2024;42(30):3550\u201360.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"2434_CR40","doi-asserted-by":"crossref","unstructured":"Ter Brugge P et al. Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers. Nat Comm, 2023. 14(1): p. 1958.","DOI":"10.1038\/s41467-023-37537-2"},{"issue":"13","key":"2434_CR41","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/1078-0432.CCR-22-3335","volume":"29","author":"AJ Compadre","year":"2023","unstructured":"Compadre AJ, et al. RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2023;29(13):2466\u201379.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"7612","key":"2434_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature18325","volume":"535","author":"A Ray Chaudhuri","year":"2016","unstructured":"Ray Chaudhuri A, et al. Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature. 2016;535(7612):382\u20137.","journal-title":"Nature"},{"issue":"1","key":"2434_CR43","doi-asserted-by":"publisher","first-page":"2532224","DOI":"10.1080\/15384047.2025.2532224","volume":"26","author":"JW He","year":"2025","unstructured":"He JW, Li PZ, Huang ZX. Copper death combination therapy: the innovative frontier and challenges in prostate cancer treatment. Cancer Biol Ther. 2025;26(1):2532224.","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"2434_CR44","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41419-024-06945-7","volume":"15","author":"N Li","year":"2024","unstructured":"Li N, et al. PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell Death Dis. 2024;15(8):555.","journal-title":"Cell Death Dis"},{"key":"2434_CR45","doi-asserted-by":"crossref","unstructured":"He J et al. Mechanisms and management of 3rd\u2013generation EGFR\u2013TKI resistance in advanced non\u2013small cell lung cancer (Review). Int J Oncol, 2021. 59(5).","DOI":"10.3892\/ijo.2021.5270"},{"key":"2434_CR46","doi-asserted-by":"publisher","first-page":"1512509","DOI":"10.3389\/fimmu.2025.1512509","volume":"16","author":"X Han","year":"2025","unstructured":"Han X, et al. The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategies. Front Immunol. 2025;16:1512509.","journal-title":"Front Immunol"},{"key":"2434_CR47","first-page":"e08040","volume-title":"Personalized neoantigen vaccine plus regorafenib increases Rgs2\u207aCD8\u207a T cells infiltration and reprograms the tumor microenvironment in microsatellite stable colorectal cancer liver metastases","author":"H Chen","year":"2025","unstructured":"Chen H, et al. Personalized neoantigen vaccine plus regorafenib increases Rgs2\u207aCD8\u207a T cells infiltration and reprograms the tumor microenvironment in microsatellite stable colorectal cancer liver metastases. Baden-Wurttemberg, Germany): Advanced Science (Weinheim; 2025. p. e08040."},{"key":"2434_CR48","doi-asserted-by":"crossref","unstructured":"Shackleton EG, et al. Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer. Cancers (Basel). 2021;13(5):1145.","DOI":"10.3390\/cancers13051145"},{"issue":"1","key":"2434_CR49","doi-asserted-by":"publisher","first-page":"2468312","DOI":"10.1080\/19420862.2025.2468312","volume":"17","author":"F Bick","year":"2025","unstructured":"Bick F, et al. Targeting \u03b3c family cytokines with biologics: current status and future prospects. MAbs. 2025;17(1):2468312.","journal-title":"MAbs"},{"issue":"1","key":"2434_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43018-020-00148-7","volume":"2","author":"AK Mehta","year":"2021","unstructured":"Mehta AK, et al. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer. Nat Cancer. 2021;2(1):66\u201382.","journal-title":"Nat Cancer"},{"key":"2434_CR51","doi-asserted-by":"publisher","first-page":"153737","DOI":"10.1016\/j.phymed.2021.153737","volume":"92","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, et al. Anticancer effects of Asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2021;92:153737.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"2434_CR52","doi-asserted-by":"publisher","first-page":"656364","DOI":"10.3389\/fimmu.2021.656364","volume":"12","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, et al. Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Front Immunol. 2021;12:656364.","journal-title":"Front Immunol"},{"key":"2434_CR53","doi-asserted-by":"publisher","first-page":"109052","DOI":"10.1016\/j.jmgm.2025.109052","volume":"138","author":"C Wei","year":"2025","unstructured":"Wei C, et al. Identification of novel inhibitors targeting EGFR L858R\/T790M\/C797S against NSCLC by molecular docking, MD simulation, and DFT approaches. J Mol Graph Model. 2025;138:109052.","journal-title":"J Mol Graph Model"},{"issue":"1","key":"2434_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cbin.12249","volume":"49","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. EML4-ALK G1202R and EML4-ALK L1196M mutations induce Crizotinib resistance in non-small cell lung cancer cells through activating epithelial-mesenchymal transition mediated by MDM2\/MEK\/ERK signal axis. Cell Biol Int. 2025;49(1):55\u201367.","journal-title":"Cell Biol Int"},{"key":"2434_CR55","doi-asserted-by":"publisher","first-page":"102418","DOI":"10.1016\/j.ctrv.2022.102418","volume":"108","author":"D Blang\u00e9","year":"2022","unstructured":"Blang\u00e9 D, et al. Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review. Cancer Treat Rev. 2022;108:102418.","journal-title":"Cancer Treat Rev"},{"issue":"21","key":"2434_CR56","doi-asserted-by":"publisher","first-page":"e40118","DOI":"10.1016\/j.heliyon.2024.e40118","volume":"10","author":"F Du","year":"2024","unstructured":"Du F, et al. Endothelial-to-mesenchymal transition in the tumor microenvironment: roles of transforming growth factor-\u03b2 and matrix metalloproteins. Heliyon. 2024;10(21):e40118.","journal-title":"Heliyon"},{"key":"2434_CR57","doi-asserted-by":"publisher","first-page":"155992","DOI":"10.1016\/j.prp.2025.155992","volume":"270","author":"K Mortezaee","year":"2025","unstructured":"Mortezaee K. EZH2 regulatory roles in cancer immunity and immunotherapy. Pathol Res Pract. 2025;270:155992.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2434_CR58","doi-asserted-by":"publisher","first-page":"189344","DOI":"10.1016\/j.bbcan.2025.189344","volume":"1880","author":"L Liu","year":"2025","unstructured":"Liu L, Li Y, Li B. Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment. Biochim Et Biophys Acta Reviews Cancer. 2025;1880(3):189344.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"key":"2434_CR59","doi-asserted-by":"crossref","unstructured":"Zhang X, Ye X, Jin H. Oxidized Low-Density Lipoprotein as a Potential Target for Enhancing Immune Checkpoint Inhibitor Therapy in Microsatellite-Stable Colorectal Cancer. Antioxidants (Basel, Switzerland), 2025. 14(6).\u00a0","DOI":"10.3390\/antiox14060726"},{"key":"2434_CR60","doi-asserted-by":"publisher","unstructured":"Chen Y, et al. Gal-1 promotes lung cancer cell survival by enhancing PARP1\/H1.2 interaction to promote DNA repair upon DNA damage response. FEBS J. 2025. https:\/\/doi.org\/10.1111\/febs.70134. Epub ahead of print. PMID: 40365664.","DOI":"10.1111\/febs.70134"},{"issue":"12","key":"2434_CR61","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1111\/epi.17410","volume":"63","author":"J Gesche","year":"2022","unstructured":"Gesche J, Beier CP. Drug resistance in idiopathic generalized epilepsies: evidence and concepts. Epilepsia. 2022;63(12):3007\u201319.","journal-title":"Epilepsia"},{"key":"2434_CR62","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.gde.2022.101965","volume":"76","author":"AC Gerstein","year":"2022","unstructured":"Gerstein AC, Sethi P. Experimental evolution of drug resistance in human fungal pathogens. Curr Opin Genet Dev. 2022;76:101965.","journal-title":"Curr Opin Genet Dev"},{"key":"2434_CR63","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","volume":"53","author":"N Erin","year":"2020","unstructured":"Erin N, et al. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2020;53:100715.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"3","key":"2434_CR64","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.apsb.2020.10.022","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Hedgehog signaling in Gastrointestinal carcinogenesis and the Gastrointestinal tumor microenvironment. Acta Pharm Sinica B. 2021;11(3):609\u201320.","journal-title":"Acta Pharm Sinica B"},{"issue":"1","key":"2434_CR65","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12967-024-05541-9","volume":"22","author":"M Pude\u0142ek","year":"2024","unstructured":"Pude\u0142ek M, et al. Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress. J Translational Med. 2024;22(1):757.","journal-title":"J Translational Med"},{"key":"2434_CR66","doi-asserted-by":"crossref","unstructured":"Filippi A, et al. Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer. Int J Mol Sci. 2025;26(2):631.","DOI":"10.3390\/ijms26020631"},{"key":"2434_CR67","doi-asserted-by":"crossref","unstructured":"Deldar Abad Paskeh M, et al. Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies. Int J Mol Sci. 2021;22(21):11669.","DOI":"10.3390\/ijms222111669"},{"issue":"6","key":"2434_CR68","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1021\/acs.jmedchem.0c02199","volume":"64","author":"V Namasivayam","year":"2021","unstructured":"Namasivayam V, et al. C@PA: Computer-Aided pattern analysis to predict multitarget ABC transporter inhibitors. J Med Chem. 2021;64(6):3350\u201366.","journal-title":"J Med Chem"},{"issue":"8","key":"2434_CR69","doi-asserted-by":"publisher","first-page":"923","DOI":"10.7150\/ijbs.10896","volume":"11","author":"H-B Kim","year":"2015","unstructured":"Kim H-B, et al. Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 Inhibition. Int J Biol Sci. 2015;11(8):923\u201334.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"2434_CR70","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.7150\/thno.103722","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, et al. A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2-loaded small extracellular vesicles. Theranostics. 2025;15(8):3439\u201361.","journal-title":"Theranostics"},{"key":"2434_CR71","doi-asserted-by":"publisher","first-page":"114001","DOI":"10.1016\/j.jconrel.2025.114001","volume":"385","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. Enhancing antigen presentation in cancer stem cells via peptide-based nanoparticles for effective immunotherapy. J Controlled Release: Official J Controlled Release Soc. 2025;385:114001.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"2434_CR72","doi-asserted-by":"crossref","unstructured":"Guan Q et al. The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts. Cells, 2024. 13(18).","DOI":"10.3390\/cells13181545"},{"key":"2434_CR73","doi-asserted-by":"crossref","unstructured":"Singh RP, et al. Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-Renewal. Cell Stem Cell. 2020;26(6):926\u201337.","DOI":"10.1016\/j.stem.2020.04.010"},{"issue":"22","key":"2434_CR74","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1158\/1078-0432.CCR-19-1176","volume":"25","author":"E Pailler","year":"2019","unstructured":"Pailler E, et al. Acquired resistance mutations to ALK inhibitors identified by single Circulating tumor cell sequencing in ALK-Rearranged Non-Small-Cell lung cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2019;25(22):6671\u201382.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"2434_CR75","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12915-021-01147-5","volume":"19","author":"H Ono","year":"2021","unstructured":"Ono H, et al. Single-cell DNA and RNA sequencing reveals the dynamics of intra-tumor heterogeneity in a colorectal cancer model. BMC Biol. 2021;19(1):207.","journal-title":"BMC Biol"},{"issue":"2","key":"2434_CR76","doi-asserted-by":"publisher","first-page":"46","DOI":"10.62347\/YODE5431","volume":"18","author":"X Li","year":"2025","unstructured":"Li X, et al. Sequencing of high-frequency mutated genes in breast cancer (BRCA) and associated-functions analysis. Int J Clin Exp Pathol. 2025;18(2):46\u201362.","journal-title":"Int J Clin Exp Pathol"},{"key":"2434_CR77","doi-asserted-by":"crossref","unstructured":"Wang H, et al. Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer. Nat Cancer. 2025;6(4):629\u201346.","DOI":"10.1038\/s43018-025-00928-z"},{"issue":"21","key":"2434_CR78","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1158\/0008-5472.CAN-20-1192","volume":"80","author":"Y Lu","year":"2020","unstructured":"Lu Y, et al. Hypoxia induces resistance to EGFR inhibitors in lung cancer cells via upregulation of FGFR1 and the MAPK pathway. Cancer Res. 2020;80(21):4655\u201367.","journal-title":"Cancer Res"},{"issue":"1","key":"2434_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22(1):40.","journal-title":"Mol Cancer"},{"key":"2434_CR80","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-14-4","volume":"14","author":"C Fischer","year":"2015","unstructured":"Fischer C, et al. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1\u03b1 destabilization. Mol Cancer. 2015;14:4.","journal-title":"Mol Cancer"},{"issue":"19","key":"2434_CR81","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1158\/0008-5472.CAN-12-0979","volume":"72","author":"J Kluza","year":"2012","unstructured":"Kluza J, et al. Inactivation of the HIF-1\u03b1\/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res. 2012;72(19):5035\u201347.","journal-title":"Cancer Res"},{"issue":"1","key":"2434_CR82","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1186\/s12951-024-03011-4","volume":"22","author":"N Shao","year":"2024","unstructured":"Shao N, et al. Synergistic enhancement of low-dose radiation therapy via Cuproptosis and metabolic reprogramming for radiosensitization in in situ hepatocellular carcinoma. J Nanobiotechnol. 2024;22(1):772.","journal-title":"J Nanobiotechnol"},{"key":"2434_CR83","doi-asserted-by":"publisher","first-page":"1031539","DOI":"10.3389\/fimmu.2022.1031539","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. A broad Cuproptosis landscape in inflammatory bowel disease. Front Immunol. 2022;13:1031539.","journal-title":"Front Immunol"},{"key":"2434_CR84","doi-asserted-by":"publisher","first-page":"123379","DOI":"10.1016\/j.lfs.2025.123379","volume":"363","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Metallothionein rescues doxorubicin cardiomyopathy via mitigation of Cuproptosis. Life Sci. 2025;363:123379.","journal-title":"Life Sci"},{"key":"2434_CR85","doi-asserted-by":"crossref","unstructured":"Sun Z et al. AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple-Negative Breast Cancer. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2025: p. e2408106.","DOI":"10.1002\/advs.202408106"},{"key":"2434_CR86","doi-asserted-by":"publisher","first-page":"103260","DOI":"10.1016\/j.redox.2024.103260","volume":"75","author":"L Qiao","year":"2024","unstructured":"Qiao L, et al. Tumor microenvironment activation amplify oxidative stress promoting tumor energy remodeling for mild photothermal therapy and Cuproptosis. Redox Biol. 2024;75:103260.","journal-title":"Redox Biol"},{"key":"2434_CR87","doi-asserted-by":"crossref","unstructured":"Ghai S, et al. The Role of Heat Shock Factor 1 in Preserving Proteomic Integrity During Copper-Induced Cellular Toxicity. Int J Mol Sci. 2024;25(21):11657.","DOI":"10.3390\/ijms252111657"},{"issue":"11","key":"2434_CR88","doi-asserted-by":"publisher","first-page":"e0251957","DOI":"10.1371\/journal.pone.0251957","volume":"16","author":"R Serra","year":"2021","unstructured":"Serra R, et al. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a Medulloblastoma model. PLoS ONE. 2021;16(11):e0251957.","journal-title":"PLoS ONE"},{"issue":"8","key":"2434_CR89","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, et al. Copper metabolism in cell death and autophagy. Autophagy. 2023;19(8):2175\u201395.","journal-title":"Autophagy"},{"key":"2434_CR90","first-page":"e2500652","volume-title":"A Copper-Based Photothermal-Responsive nanoplatform reprograms tumor immunogenicity via Self-Amplified Cuproptosis for synergistic cancer therapy","author":"R Cheng","year":"2025","unstructured":"Cheng R, et al. A Copper-Based Photothermal-Responsive nanoplatform reprograms tumor immunogenicity via Self-Amplified Cuproptosis for synergistic cancer therapy. Baden-Wurttemberg, Germany): Advanced Science (Weinheim; 2025. p. e2500652."},{"key":"2434_CR91","doi-asserted-by":"crossref","unstructured":"Lei G, et al. The potential of targeting Cuproptosis in the treatment of kidney renal clear cell carcinoma. Volume 167. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2023. p. 115522.","DOI":"10.1016\/j.biopha.2023.115522"},{"issue":"1","key":"2434_CR92","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, et al. The molecular mechanism and therapeutic landscape of copper and Cuproptosis in cancer. Signal Transduct Target Therapy. 2025;10(1):149.","journal-title":"Signal Transduct Target Therapy"},{"issue":"30","key":"2434_CR93","first-page":"pe2401396","volume":"11","author":"X Gao","year":"2024","unstructured":"Gao X, et al. Enzalutamide sensitizes Castration-Resistant prostate cancer to Copper-Mediated cell death. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11(30):pe2401396.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"2434_CR94","doi-asserted-by":"publisher","first-page":"112075","DOI":"10.1016\/j.intimp.2024.112075","volume":"133","author":"Y Zou","year":"2024","unstructured":"Zou Y, et al. Cope with copper: from molecular mechanisms of Cuproptosis to copper-related kidney diseases. Int Immunopharmacol. 2024;133:112075.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2434_CR95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s11658-024-00623-4","volume":"29","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, et al. Triptolide-induced Cuproptosis is a novel antitumor strategy for the treatment of cervical cancer. Cell Mol Biol Lett. 2024;29(1):113.","journal-title":"Cell Mol Biol Lett"},{"issue":"11","key":"2434_CR96","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","volume":"17","author":"S Ning","year":"2023","unstructured":"Ning S, et al. Type-I AIE photosensitizer loaded biomimetic system boosting Cuproptosis to inhibit breast cancer metastasis and Rechallenge. ACS Nano. 2023;17(11):10206\u201317.","journal-title":"ACS Nano"},{"issue":"9\u201310","key":"2434_CR97","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10495-024-01978-x","volume":"29","author":"R Jawed","year":"2024","unstructured":"Jawed R, Bhatti H. Cuproptosis in lung cancer: therapeutic options and prognostic models. Apoptosis: Int J Program Cell Death. 2024;29(9\u201310):1393\u20138.","journal-title":"Apoptosis: Int J Program Cell Death"},{"key":"2434_CR98","doi-asserted-by":"publisher","first-page":"135391","DOI":"10.1016\/j.jhazmat.2024.135391","volume":"477","author":"S Wu","year":"2024","unstructured":"Wu S, et al. Copper mediated follicular atresia: implications for granulosa cell death. J Hazard Mater. 2024;477:135391.","journal-title":"J Hazard Mater"},{"issue":"8","key":"2434_CR99","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s00277-024-05841-6","volume":"103","author":"M Abulimiti","year":"2024","unstructured":"Abulimiti M, et al. Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia. Ann Hematol. 2024;103(8):2797\u2013826.","journal-title":"Ann Hematol"},{"key":"2434_CR100","doi-asserted-by":"publisher","first-page":"1123231","DOI":"10.3389\/fimmu.2023.1123231","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints. Front Immunol. 2023;14:1123231.","journal-title":"Front Immunol"},{"issue":"1","key":"2434_CR101","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1152\/physrev.00011.2024","volume":"105","author":"S Lutsenko","year":"2025","unstructured":"Lutsenko S, Roy S, Tsvetkov P. Mammalian copper homeostasis: physiological roles and molecular mechanisms. Physiol Rev. 2025;105(1):441\u201391.","journal-title":"Physiol Rev"},{"key":"2434_CR102","doi-asserted-by":"publisher","first-page":"981764","DOI":"10.3389\/fimmu.2022.981764","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, et al. Multi-omics pan-cancer study of Cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma. Front Immunol. 2022;13:981764.","journal-title":"Front Immunol"},{"key":"2434_CR103","doi-asserted-by":"crossref","unstructured":"Xie M, et al.Cuproptosis-Related MiR-21-5p\/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment. Cells. 2022;12(1):173.","DOI":"10.3390\/cells12010173"},{"key":"2434_CR104","doi-asserted-by":"crossref","unstructured":"Prasad Panda S, Kesharwani A. Micronutrients\/miRs\/ATP networking in mitochondria: clinical intervention with ferroptosis, cuproptosis, and calcium burden. Mitochondrion. 2023;71:1\u201316.","DOI":"10.1016\/j.mito.2023.05.003"},{"issue":"6","key":"2434_CR105","doi-asserted-by":"publisher","first-page":"189013","DOI":"10.1016\/j.bbcan.2023.189013","volume":"1878","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Cuproptosis and cuproptosis-related genes: emerging potential therapeutic targets in breast cancer. Biochim Et Biophys Acta Reviews Cancer. 2023;1878(6):189013.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"issue":"23","key":"2434_CR106","first-page":"pe2402516","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, et al. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in glioblastoma therapy. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11(23):pe2402516.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"1","key":"2434_CR107","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12672-024-01129-3","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, et al. Prognostic value of oxidative phosphorylation-related genes in hepatocellular carcinoma. Discover Oncol. 2024;15(1):258.","journal-title":"Discover Oncol"},{"issue":"10","key":"2434_CR108","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.devcel.2024.12.035","volume":"60","author":"Y Cao","year":"2025","unstructured":"Cao Y, et al. DYRK1A-TGF-\u03b2 signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma. Dev Cell. 2025;60(10):1483\u20131497.e7.","journal-title":"Dev Cell."},{"key":"2434_CR109","doi-asserted-by":"publisher","first-page":"118444","DOI":"10.1016\/j.jep.2024.118444","volume":"333","author":"J Yang","year":"2024","unstructured":"Yang J, et al. Qiju Dihuang pill protects the lens epithelial cells via alleviating Cuproptosis in diabetic cataract. J Ethnopharmacol. 2024;333:118444.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2434_CR110","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and Cuproptosis in health and disease. Signal Transduct Target Therapy. 2022;7(1):378.","journal-title":"Signal Transduct Target Therapy"},{"issue":"9","key":"2434_CR111","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian K, Stockwell BR. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discov. 2023;22(9):723\u201342.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2434_CR112","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M. Rotenone-Induced model of parkinson\u2019s disease: beyond mitochondrial complex I Inhibition. Mol Neurobiol. 2023;60(4):1929\u201348.","journal-title":"Mol Neurobiol"},{"key":"2434_CR113","doi-asserted-by":"crossref","unstructured":"Zikaki K, et al. Villains turning good: antimycin A and rotenone, mitochondrial respiratory chain inhibitors, protect H9c2 cardiac cells against insults triggering the intrinsic apoptotic pathway. Int J Mol Sci. 2025;26(6):2435.","DOI":"10.3390\/ijms26062435"},{"key":"2434_CR114","doi-asserted-by":"crossref","unstructured":"Cai X, et al. Lactate activates the mitochondrial electron transport chain independently of its metabolism. Mol Cell. 2023;83(21):3904\u20133920.e7.","DOI":"10.1016\/j.molcel.2023.09.034"},{"key":"2434_CR115","doi-asserted-by":"publisher","first-page":"1082974","DOI":"10.3389\/fimmu.2023.1082974","volume":"14","author":"B Zhang","year":"2023","unstructured":"Zhang B, et al. Construction and validation of a cuproptosis-related prognostic model for glioblastoma. Front Immunol. 2023;14:1082974.","journal-title":"Front Immunol"},{"issue":"14","key":"2434_CR116","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1177\/09612033231211429","volume":"32","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Exploring the role of LIAS-related Cuproptosis in systemic lupus erythematosus. Lupus. 2023;32(14):1598\u2013609.","journal-title":"Lupus"},{"key":"2434_CR117","doi-asserted-by":"crossref","unstructured":"Wang D, et al. The molecular mechanisms of Cuproptosis and its relevance to cardiovascular disease. Volume 163. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2023. p. 114830.","DOI":"10.1016\/j.biopha.2023.114830"},{"key":"2434_CR118","doi-asserted-by":"crossref","unstructured":"Li H, et al. GSH exhaustion via Inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF\/Cu-induced Cuproptosis in myelodysplastic syndromes. Volume 222. Free Radical Biology & Medicine; 2024. pp. 130\u201348.","DOI":"10.1016\/j.freeradbiomed.2024.06.006"},{"key":"2434_CR119","doi-asserted-by":"publisher","first-page":"1409620","DOI":"10.3389\/fonc.2024.1409620","volume":"14","author":"S Liu","year":"2024","unstructured":"Liu S, et al. The signature genes of Cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma. Front Oncol. 2024;14:1409620.","journal-title":"Front Oncol"},{"issue":"1","key":"2434_CR120","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12672-024-00981-7","volume":"15","author":"B Yang","year":"2024","unstructured":"Yang B, Yang J, Zhang K. A cuproptosis-related signature predicts prognosis and indicates cross-talk with immunocyte in ovarian cancer. Discover Oncol. 2024;15(1):141.","journal-title":"Discover Oncol"},{"key":"2434_CR121","doi-asserted-by":"publisher","first-page":"137326","DOI":"10.1016\/j.jcis.2025.137326","volume":"690","author":"Q Li","year":"2025","unstructured":"Li Q, et al. Biodegradable nano-immune agonist for enhanced immunotherapy of melanoma via the synergistic action of Cuproptosis and cGAS-STING enhanced immune response. J Colloid Interface Sci. 2025;690:137326.","journal-title":"J Colloid Interface Sci"},{"key":"2434_CR122","doi-asserted-by":"crossref","unstructured":"Gurung S, et al. Stromal lipid species dictate melanoma metastasis and tropism. Cancer Cell. 2025;43(6):1108\u20131124.e11.","DOI":"10.1016\/j.ccell.2025.04.001"},{"key":"2434_CR123","doi-asserted-by":"publisher","first-page":"1174762","DOI":"10.3389\/fimmu.2023.1174762","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, et al. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing. Front Immunol. 2023;14:1174762.","journal-title":"Front Immunol"},{"issue":"2","key":"2434_CR124","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2434_CR125","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32(5):417\u20138.","journal-title":"Cell Res"},{"key":"2434_CR126","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Gonz\u00e1lez C, et al. Effect of Bis(maltolato)oxovanadium(IV) on Zinc, Copper, and Manganese Homeostasis and DMT1 mRNA Expression in Streptozotocin-Induced Hyperglycemic Rats. Biology (Basel). 2022;11(6):814.","DOI":"10.3390\/biology11060814"},{"issue":"5","key":"2434_CR127","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s13577-022-00748-8","volume":"35","author":"L Fu","year":"2022","unstructured":"Fu L, et al. Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression. Hum Cell. 2022;35(5):1560\u201376.","journal-title":"Hum Cell"},{"key":"2434_CR128","doi-asserted-by":"crossref","unstructured":"Moenne A et al. Mechanisms of Copper Tolerance, Accumulation, and Detoxification in the Marine Macroalga Ulva compressa (Chlorophyta): 20 Years of Research. Plants (Basel, Switzerland), 2020. 9(6).","DOI":"10.3390\/plants9060681"},{"key":"2434_CR129","doi-asserted-by":"crossref","unstructured":"Haque E, et al. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines. Int J Mol Sci. 2021;22(10):5296.","DOI":"10.3390\/ijms22105296"},{"issue":"6","key":"2434_CR130","doi-asserted-by":"publisher","first-page":"e70453","DOI":"10.1096\/fj.202403002R","volume":"39","author":"X Wang","year":"2025","unstructured":"Wang X, et al. Spermidine alleviates copper-induced oxidative stress, inflammation and Cuproptosis in the liver. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2025;39(6):e70453.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"2434_CR131","doi-asserted-by":"crossref","unstructured":"Zhang M, et al. Synchronously evoking Disulfidptosis and ferroptosis via systematical glucose deprivation targeting SLC7A11\/GSH\/GPX4 antioxidant axis. ACS Nano; 2025.","DOI":"10.1021\/acsnano.5c00730"},{"key":"2434_CR132","doi-asserted-by":"publisher","first-page":"122675","DOI":"10.1016\/j.biomaterials.2024.122675","volume":"311","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. In situ hydrogel based on Cu-Fe3O4 nanoclusters exploits oxidative stress and the ferroptosis\/cuproptosis pathway for chemodynamic therapy. Biomaterials. 2024;311:122675.","journal-title":"Biomaterials"},{"issue":"6","key":"2434_CR133","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.kint.2022.07.034","volume":"102","author":"Y Ye","year":"2022","unstructured":"Ye Y, et al. Repression of the antiporter SLC7A11\/glutathione\/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 2022;102(6):1259\u201375.","journal-title":"Kidney Int"},{"key":"2434_CR134","doi-asserted-by":"crossref","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Volume 152. Free Radical Biology & Medicine; 2020. pp. 175\u201385.","DOI":"10.1016\/j.freeradbiomed.2020.02.027"},{"key":"2434_CR135","doi-asserted-by":"publisher","first-page":"110262","DOI":"10.1016\/j.cbi.2022.110262","volume":"369","author":"S Cai","year":"2023","unstructured":"Cai S, et al. Trabectedin induces ferroptosis via regulation of HIF-1\u03b1\/IRP1\/TFR1 and Keap1\/Nrf2\/GPX4 axis in non-small cell lung cancer cells. Chemico-Biol Interact. 2023;369:110262.","journal-title":"Chemico-Biol Interact"},{"key":"2434_CR136","doi-asserted-by":"publisher","first-page":"110373","DOI":"10.1016\/j.cbi.2023.110373","volume":"373","author":"KR Washimkar","year":"2023","unstructured":"Washimkar KR, et al. Benzo[a]pyrene treatment modulates Nrf2\/Keap1 axis and changes the metabolic profile in rat lung cancer. Chemico-Biol Interact. 2023;373:110373.","journal-title":"Chemico-Biol Interact"},{"issue":"1","key":"2434_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.24-14","volume":"75","author":"T Kamiya","year":"2024","unstructured":"Kamiya T. Role of copper and SOD3-mediated extracellular redox regulation in tumor progression. J Clin Biochem Nutr. 2024;75(1):1\u20136.","journal-title":"J Clin Biochem Nutr"},{"key":"2434_CR138","doi-asserted-by":"crossref","unstructured":"Song X, et al. Reprogramming of Energy Metabolism in Human PKD1 Polycystic Kidney Disease: A Systems Biology Analysis. Int J Mol Sci. 2024;25(13):7173.","DOI":"10.3390\/ijms25137173"},{"issue":"23","key":"2434_CR139","first-page":"pe2401738","volume":"11","author":"X Wei","year":"2024","unstructured":"Wei X, et al. Boosting energy deprivation by synchronous interventions of Glycolysis and oxidative phosphorylation for bioenergetic therapy synergetic with chemodynamic\/photothermal therapy. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11(23):pe2401738.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"9","key":"2434_CR140","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon MB, et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem. 2023;299(9):105046.","journal-title":"J Biol Chem"},{"issue":"2","key":"2434_CR141","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19(2):206\u201317.","journal-title":"Nat Chem Biol"},{"key":"2434_CR142","doi-asserted-by":"publisher","first-page":"963639","DOI":"10.3389\/fmolb.2023.963639","volume":"10","author":"W Huang","year":"2023","unstructured":"Huang W, et al. Pan-cancer integrated bioinformatics analysis reveals Cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Front Mol Biosci. 2023;10:963639.","journal-title":"Front Mol Biosci"},{"issue":"8","key":"2434_CR143","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.123.322676","volume":"133","author":"S Serio","year":"2023","unstructured":"Serio S, et al. Cardiac aging is promoted by pseudohypoxia increasing p300-Induced Glycolysis. Circul Res. 2023;133(8):687\u2013703.","journal-title":"Circul Res"},{"key":"2434_CR144","doi-asserted-by":"crossref","unstructured":"Ma Y, Zheng W. Correction: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p\/PCBP2 axis. J of Ovarian Res, 2022. 15(1): p. 108.","DOI":"10.1186\/s13048-022-01038-5"},{"issue":"7","key":"2434_CR145","doi-asserted-by":"publisher","first-page":"110357","DOI":"10.1016\/j.celrep.2022.110357","volume":"38","author":"A Segelle","year":"2022","unstructured":"Segelle A, et al. Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing. Cell Rep. 2022;38(7):110357.","journal-title":"Cell Rep"},{"issue":"4","key":"2434_CR146","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.jcmgh.2021.05.020","volume":"12","author":"GV Sarode","year":"2021","unstructured":"Sarode GV, et al. Wilson disease: intersecting DNA methylation and histone acetylation regulation of gene expression in a mouse model of hepatic copper accumulation. Cell Mol Gastroenterol Hepatol. 2021;12(4):1457\u201377.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"2434_CR147","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1021\/acsptsci.4c00681","volume":"8","author":"R Kumari","year":"2025","unstructured":"Kumari R, Banerjee S. Regulation of different types of cell death by noncoding rnas: molecular insights and therapeutic implications. ACS Pharmacol Translational Sci. 2025;8(5):1205\u201326.","journal-title":"ACS Pharmacol Translational Sci"},{"key":"2434_CR148","doi-asserted-by":"publisher","first-page":"1555782","DOI":"10.3389\/fimmu.2025.1555782","volume":"16","author":"M Kuang","year":"2025","unstructured":"Kuang M, et al. Big data analysis and machine learning of the role of cuproptosis-related long non-coding RNAs (CuLncs) in the prognosis and immune landscape of ovarian cancer. Front Immunol. 2025;16:1555782.","journal-title":"Front Immunol"},{"issue":"1","key":"2434_CR149","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12885-025-13533-1","volume":"25","author":"W Liu","year":"2025","unstructured":"Liu W, et al. Lidocaine could promote the Cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells. BMC Cancer. 2025;25(1):119.","journal-title":"BMC Cancer"},{"issue":"21","key":"2434_CR150","doi-asserted-by":"publisher","first-page":"e2500337","DOI":"10.1002\/adma.202500337","volume":"37","author":"B Liu","year":"2025","unstructured":"Liu B, et al. One-Step symbiosis of bimetallic peroxides nanoparticles to induce ferroptosis\/cuproptosis and activate cGAS-STING pathway for enhanced tumor immunotherapy. Adv Mater (Deerfield Beach Fla). 2025;37(21):e2500337.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"2434_CR151","doi-asserted-by":"crossref","unstructured":"Yang H, et al. C5a\/C5aR pathway blocking promoted CuS-mediated cancer therapy effect by inhibiting cuproptosis resistance. J Immunother Cancer. 2025;13(6):e011472.","DOI":"10.1136\/jitc-2025-011472"},{"issue":"11","key":"2434_CR152","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","volume":"31","author":"Y-T Liu","year":"2024","unstructured":"Liu Y-T, et al. Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to Cuproptosis in cancer cells. Cell Death Differ. 2024;31(11):1452\u201366.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2434_CR153","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/jcmm.17682","volume":"27","author":"M De Felice","year":"2023","unstructured":"De Felice M, et al. Intermittent hypoxia treatments cause cellular priming in human microglia. J Cell Mol Med. 2023;27(6):819\u201330.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2434_CR154","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12935-024-03220-9","volume":"24","author":"M-Y Hsieh","year":"2024","unstructured":"Hsieh M-Y, et al. Melanoma biology and treatment: a review of novel regulated cell death-based approaches. Cancer Cell Int. 2024;24(1):63.","journal-title":"Cancer Cell Int"},{"key":"2434_CR155","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun B, et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024;75:103302.","journal-title":"Redox Biol"},{"issue":"11","key":"2434_CR156","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, et al. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 2023;14(11):733.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2434_CR157","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1080\/15548627.2021.2016231","volume":"18","author":"S Zhang","year":"2022","unstructured":"Zhang S, et al. Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis. Autophagy. 2022;18(9):2229\u201345.","journal-title":"Autophagy"},{"issue":"8","key":"2434_CR158","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.it.2020.06.002","volume":"41","author":"L Villanueva","year":"2020","unstructured":"Villanueva L, \u00c1lvarez-Errico D, Esteller M. The contribution of epigenetics to cancer immunotherapy. Trends Immunol. 2020;41(8):676\u201391.","journal-title":"Trends Immunol"},{"issue":"10","key":"2434_CR159","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller M, et al. The epigenetic hallmarks of cancer. Cancer Discov. 2024;14(10):1783\u2013809.","journal-title":"Cancer Discov"},{"issue":"7","key":"2434_CR160","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 2022;38(7):676\u2013707.","journal-title":"Trends Genet"},{"key":"2434_CR161","doi-asserted-by":"crossref","unstructured":"Hitchins MP, et al. Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger. J Natl Compr Canc Netw. 2023;21(7):743\u2013752.e11.","DOI":"10.6004\/jnccn.2023.7020"},{"issue":"1","key":"2434_CR162","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Therapy. 2024;9(1):232.","journal-title":"Signal Transduct Target Therapy"},{"issue":"12","key":"2434_CR163","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.tig.2020.07.011","volume":"36","author":"RC Centore","year":"2020","unstructured":"Centore RC, et al. Mammalian SWI\/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies. Trends Genet. 2020;36(12):936\u201350.","journal-title":"Trends Genet"},{"key":"2434_CR164","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fonc.2013.00007","volume":"3","author":"L Zhang","year":"2013","unstructured":"Zhang L, et al. The chromatin remodeling protein BRG1 modulates BRCA1 response to UV irradiation by regulating ATR\/ATM activation. Front Oncol. 2013;3:7.","journal-title":"Front Oncol"},{"key":"2434_CR165","doi-asserted-by":"crossref","unstructured":"Kumar S, et al. Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia. Biomedicines. 2021;9(6):690.","DOI":"10.3390\/biomedicines9060690"},{"key":"2434_CR166","doi-asserted-by":"crossref","unstructured":"Kumar S, et al. Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH. Cells. 2021;10(9):2250.","DOI":"10.3390\/cells10092250"},{"issue":"2","key":"2434_CR167","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11010-020-03895-4","volume":"476","author":"SC Tyagi","year":"2021","unstructured":"Tyagi SC, Stanisic D, Singh M. Epigenetic memory: gene writer, eraser and homocysteine. Mol Cell Biochem. 2021;476(2):507\u201312.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"2434_CR168","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.gendis.2023.02.054","volume":"11","author":"L Sun","year":"2024","unstructured":"Sun L, et al. Decoding m6A mRNA methylation by reader proteins in liver diseases. Genes Dis. 2024;11(2):711\u201326.","journal-title":"Genes Dis"},{"issue":"3","key":"2434_CR169","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2016.02.062","volume":"165","author":"S Ramachandran","year":"2016","unstructured":"Ramachandran S, Henikoff S. Transcriptional regulators compete with nucleosomes Post-replication. Cell. 2016;165(3):580\u201392.","journal-title":"Cell"},{"issue":"1","key":"2434_CR170","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1038\/s41598-019-44941-6","volume":"9","author":"Y Suzuki","year":"2019","unstructured":"Suzuki Y, et al. Nuclear formation induced by DNA-conjugated beads in living fertilised mouse egg. Sci Rep. 2019;9(1):8461.","journal-title":"Sci Rep"},{"issue":"3","key":"2434_CR171","doi-asserted-by":"publisher","first-page":"188894","DOI":"10.1016\/j.bbcan.2023.188894","volume":"1878","author":"H Liu","year":"2023","unstructured":"Liu H, et al. Advances in epigenetic modifications and cervical cancer research. Biochim Et Biophys Acta Reviews Cancer. 2023;1878(3):188894.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"key":"2434_CR172","doi-asserted-by":"crossref","unstructured":"Ming T, et al. Curcumin: an epigenetic regulator and its application in cancer. Volume 156. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2022. p. 113956.","DOI":"10.1016\/j.biopha.2022.113956"},{"issue":"1","key":"2434_CR173","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, et al. Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer. 2024;23(1):66.","journal-title":"Mol Cancer"},{"issue":"12","key":"2434_CR174","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.18632\/aging.205945","volume":"16","author":"X Cheng","year":"2024","unstructured":"Cheng X, et al. The crosstalk role of CDKN2A between tumor progression and Cuproptosis resistance in colorectal cancer. Aging. 2024;16(12):10512\u201338.","journal-title":"Aging"},{"issue":"23","key":"2434_CR175","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2217\/epi-2023-0230","volume":"15","author":"S Qian","year":"2023","unstructured":"Qian S, et al. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation. Epigenomics. 2023;15(23):1237\u201355.","journal-title":"Epigenomics"},{"issue":"1","key":"2434_CR176","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-025-02259-0","volume":"24","author":"X Du","year":"2025","unstructured":"Du X, et al. Hsa_circ_0125356 promotes gemcitabine resistance by modulating WNT canonical and non-canonical pathways via miR-582-5p\/FGF9 axis in non-small cell lung cancer. Mol Cancer. 2025;24(1):59.","journal-title":"Mol Cancer"},{"issue":"11","key":"2434_CR177","doi-asserted-by":"publisher","first-page":"e2409187","DOI":"10.1002\/smll.202409187","volume":"21","author":"J Tao","year":"2025","unstructured":"Tao J, et al. Dual metal Nanoflower oxygen pump microneedles based on Cuproptosis and STING pathway activation for cancer immunotherapy. Small. 2025;21(11):e2409187.","journal-title":"Small"},{"issue":"1","key":"2434_CR178","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsami.1c20898","volume":"14","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, et al. siRNA-Based Carrier-Free system for synergistic chemo\/chemodynamic\/rnai therapy of Drug-Resistant tumors. ACS Appl Mater Interfaces. 2022;14(1):361\u201372.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"2434_CR179","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41467-024-54469-7","volume":"15","author":"M Guan","year":"2024","unstructured":"Guan M, et al. Regulating copper homeostasis of tumor cells to promote Cuproptosis for enhancing breast cancer immunotherapy. Nat Commun. 2024;15(1):10060.","journal-title":"Nat Commun"},{"issue":"1","key":"2434_CR180","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13046-022-02319-z","volume":"41","author":"W Huang","year":"2022","unstructured":"Huang W, et al. LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond. J Experimental Clin Cancer Research: CR. 2022;41(1):100.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"2434_CR181","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Interactions between MiRNAs and the Wnt\/\u03b2-catenin signaling pathway in endometriosis. Volume 171. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2024. p. 116182.","DOI":"10.1016\/j.biopha.2024.116182"},{"key":"2434_CR182","doi-asserted-by":"publisher","first-page":"113828","DOI":"10.1016\/j.intimp.2024.113828","volume":"146","author":"T Pan","year":"2025","unstructured":"Pan T, et al. Novel insights into Cuproptosis in alcoholic liver disease using bioinformatics analysis and experimental validation. Int Immunopharmacol. 2025;146:113828.","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"2434_CR183","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","volume":"187","author":"L-L Chen","year":"2024","unstructured":"Chen L-L, Kim VN. Small and long non-coding rnas: past, present, and future. Cell. 2024;187(23):6451\u201385.","journal-title":"Cell"},{"issue":"8","key":"2434_CR184","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","volume":"25","author":"M Coan","year":"2024","unstructured":"Coan M, et al. Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet. 2024;25(8):578\u201395.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2434_CR185","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-024-02088-7","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang H, et al. Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance. Mol Cancer. 2024;23(1):177.","journal-title":"Mol Cancer"},{"issue":"1","key":"2434_CR186","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-024-02084-x","volume":"23","author":"X Yu","year":"2024","unstructured":"Yu X, et al. The role of MicroRNAs in the gastric cancer tumor microenvironment. Mol Cancer. 2024;23(1):170.","journal-title":"Mol Cancer"},{"issue":"1","key":"2434_CR187","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/JS9.0000000000001893","volume":"111","author":"X Cai","year":"2025","unstructured":"Cai X, et al. Comprehensive analysis of cuproptosis-related genes involved in immune infiltration and their use in the diagnosis of hepatic ischemia-reperfusion injury: an experimental study. Int J Surg (London England). 2025;111(1):242\u201356.","journal-title":"Int J Surg (London England)"},{"issue":"3","key":"2434_CR188","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ncrna.2024.03.002","volume":"9","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen P, Zhao B. Role of extracellular vesicles associated with MicroRNAs and their interplay with Cuproptosis in osteoporosis. Non-coding RNA Res. 2024;9(3):715\u20139.","journal-title":"Non-coding RNA Res"},{"key":"2434_CR189","doi-asserted-by":"publisher","first-page":"e18530","DOI":"10.7717\/peerj.18530","volume":"12","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, et al. Prognosis and immune landscape of bladder cancer can be predicted using a novel MiRNA signature associated with Cuproptosis. PeerJ. 2024;12:e18530.","journal-title":"PeerJ"},{"key":"2434_CR190","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.2147\/IJN.S523766","volume":"20","author":"M Tu","year":"2025","unstructured":"Tu M, et al. Copper-Based Metal-Organic framework nanoplatform for MiRNA delivery: synergistic antitumor therapy. Int J Nanomed. 2025;20:8675\u201392.","journal-title":"Int J Nanomed"},{"key":"2434_CR191","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.2147\/OTT.S221236","volume":"12","author":"F Xiao","year":"2019","unstructured":"Xiao F, Xiao S, Xue M. miR-139 controls viability of ovarian cancer cells through apoptosis induction and exosome shedding Inhibition by targeting ATP7A. OncoTargets Therapy. 2019;12:10727\u201337.","journal-title":"OncoTargets Therapy"},{"issue":"5","key":"2434_CR192","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00280-018-3548-1","volume":"81","author":"F Xiao","year":"2018","unstructured":"Xiao F, et al. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A\/B. Cancer Chemother Pharmacol. 2018;81(5):935\u201347.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2434_CR193","doi-asserted-by":"publisher","first-page":"p111631","DOI":"10.1016\/j.cellsig.2025.111631","volume":"128","author":"S Zhang","year":"2025","unstructured":"Zhang S, et al. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression by targeting ATP7A via exosome-mediated paracrine miR-148b-3p. Cell Signal. 2025;128:p111631.","journal-title":"Cell Signal"},{"issue":"3","key":"2434_CR194","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s12013-024-01379-6","volume":"82","author":"M Shi","year":"2024","unstructured":"Shi M, Mobet Y, Shen H. Quercetin attenuates acute kidney injury caused by cisplatin by inhibiting ferroptosis and Cuproptosis. Cell Biochem Biophys. 2024;82(3):2687\u201399.","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"2434_CR195","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12885-023-10966-4","volume":"23","author":"F Ito","year":"2023","unstructured":"Ito F, et al. Matrigel-based organoid culture of malignant mesothelioma reproduces cisplatin sensitivity through CTR1. BMC Cancer. 2023;23(1):487.","journal-title":"BMC Cancer"},{"issue":"10","key":"2434_CR196","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.7150\/ijbs.83264","volume":"19","author":"Y Zou","year":"2023","unstructured":"Zou Y, et al. Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway. Int J Biol Sci. 2023;19(10):3099\u2013114.","journal-title":"Int J Biol Sci"},{"key":"2434_CR197","first-page":"217","volume-title":"Dual roles of long non-coding RNAs in thyroid cancer: regulation of programmed cell death pathways","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, et al. Dual roles of long non-coding RNAs in thyroid cancer: regulation of programmed cell death pathways. Volume 42. London, England: Medical Oncology (Northwood; 2025. p. 217. 6."},{"issue":"9","key":"2434_CR198","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.21037\/tcr-24-450","volume":"13","author":"R Duan","year":"2024","unstructured":"Duan R, et al. The LINC00957\/miR-17-5p axis regulates the cell cycle and migration in glioblastoma via the cuproptosis-related gene nephronectin. Translational Cancer Res. 2024;13(9):4923\u201337.","journal-title":"Translational Cancer Res"},{"issue":"2","key":"2434_CR199","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/1878-0261.12015","volume":"11","author":"Z Duan","year":"2017","unstructured":"Duan Z, et al. miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo. Mol Oncol. 2017;11(2):151\u201366.","journal-title":"Mol Oncol"},{"key":"2434_CR200","doi-asserted-by":"crossref","unstructured":"Xi Y et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Molecular Cancer, 2022. 21(1): p. 145.","DOI":"10.1186\/s12943-022-01615-8"},{"key":"2434_CR201","doi-asserted-by":"crossref","unstructured":"Parrella P, et al. Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer. Biomedicines. 2024;12(11):2625.","DOI":"10.3390\/biomedicines12112625"},{"key":"2434_CR202","doi-asserted-by":"crossref","unstructured":"Xu W, et al. Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1: miR-3130-5p enhances HCC growth via inhibiting FDX1. Current Molecular Pharmacology; 2025.","DOI":"10.2174\/0118761429358008250305070518"},{"issue":"9","key":"2434_CR203","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.7150\/thno.40566","volume":"10","author":"Q Meng","year":"2020","unstructured":"Meng Q, et al. A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 2020;10(9):3967\u201379.","journal-title":"Theranostics"},{"issue":"5","key":"2434_CR204","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1248\/bpb.b18-00937","volume":"42","author":"X Deng","year":"2019","unstructured":"Deng X, et al. MicroRNA-146a-5p downregulates the expression of P-Glycoprotein in rats with Lithium-Pilocarpine-Induced status epilepticus. Biol Pharm Bull. 2019;42(5):744\u201350.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"2434_CR205","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1002\/imt2.68","volume":"2","author":"C Wu","year":"2023","unstructured":"Wu C, et al. Pan-cancer analyses reveal molecular and clinical characteristics of Cuproptosis regulators. IMeta. 2023;2(1):e68.","journal-title":"IMeta"},{"issue":"3","key":"2434_CR206","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3892\/ol.2016.4892","volume":"12","author":"O Hilly","year":"2016","unstructured":"Hilly O, et al. Distinctive pattern of let-7 family MicroRNAs in aggressive carcinoma of the oral tongue in young patients. Oncol Lett. 2016;12(3):1729\u201336.","journal-title":"Oncol Lett"},{"issue":"4","key":"2434_CR207","doi-asserted-by":"publisher","first-page":"e13203","DOI":"10.1111\/eci.13203","volume":"50","author":"JH Park","year":"2020","unstructured":"Park JH, et al. Genetic variations in MicroRNA genes and cancer risk: A field synopsis and meta-analysis. Eur J Clin Invest. 2020;50(4):e13203.","journal-title":"Eur J Clin Invest"},{"key":"2434_CR208","doi-asserted-by":"publisher","first-page":"1130513","DOI":"10.3389\/fimmu.2023.1130513","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, et al. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment. Front Immunol. 2023;14:1130513.","journal-title":"Front Immunol"},{"key":"2434_CR209","doi-asserted-by":"crossref","unstructured":"Zhao J et al. Environmental copper exposure, placental cuproptosis, and miscarriage. Environmental Pollution (Barking, Essex: 1987), 2024. 348: p. 123847.","DOI":"10.1016\/j.envpol.2024.123847"},{"issue":"7","key":"2434_CR210","doi-asserted-by":"publisher","first-page":"e0132327","DOI":"10.1371\/journal.pone.0132327","volume":"10","author":"S Juz\u0117nas","year":"2015","unstructured":"Juz\u0117nas S, et al. Analysis of deregulated MicroRNAs and their target genes in gastric cancer. PLoS ONE. 2015;10(7):e0132327.","journal-title":"PLoS ONE"},{"issue":"7","key":"2434_CR211","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00262-014-1550-y","volume":"63","author":"L Miao","year":"2014","unstructured":"Miao L, et al. miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunol Immunotherapy: CII. 2014;63(7):699\u2013711.","journal-title":"Cancer Immunol Immunotherapy: CII"},{"issue":"4","key":"2434_CR212","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/cbin.11105","volume":"43","author":"L Yan","year":"2019","unstructured":"Yan L, et al. Silencing of MEG3 inhibited ox-LDL-induced inflammation and apoptosis in macrophages via modulation of the MEG3\/miR-204\/CDKN2A regulatory axis. Cell Biol Int. 2019;43(4):409\u201320.","journal-title":"Cell Biol Int"},{"issue":"4","key":"2434_CR213","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-13-2062","volume":"74","author":"CW Menges","year":"2014","unstructured":"Menges CW, et al. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res. 2014;74(4):1261\u201371.","journal-title":"Cancer Res"},{"key":"2434_CR214","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2022.05.006","volume":"186","author":"R Hao","year":"2022","unstructured":"Hao R, et al. MiR-34a-5p\/Sirt1 axis: A novel pathway for puerarin-mediated hepatoprotection against benzo(a)pyrene. Free Radic Biol Med. 2022;186:53\u201365.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2434_CR215","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41368-024-00314-y","volume":"16","author":"M Sun","year":"2024","unstructured":"Sun M, et al. Cuproptosis-related LncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p\/PLAU axis. Int J Oral Sci. 2024;16(1):63.","journal-title":"Int J Oral Sci"},{"key":"2434_CR216","doi-asserted-by":"publisher","first-page":"912037","DOI":"10.3389\/fgene.2022.912037","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y. Identification and validation of Cuproptosis-Related prognostic signature and associated regulatory axis in uterine corpus endometrial carcinoma. Front Genet. 2022;13:912037.","journal-title":"Front Genet"},{"issue":"2","key":"2434_CR217","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s10528-023-10473-y","volume":"62","author":"Y Li","year":"2024","unstructured":"Li Y, Kan X. Cuproptosis-Related genes MTF1 and LIPT1 as novel prognostic biomarker in acute myeloid leukemia. Biochem Genet. 2024;62(2):1136\u201359.","journal-title":"Biochem Genet"},{"key":"2434_CR218","doi-asserted-by":"publisher","first-page":"p9004830","DOI":"10.1155\/2022\/9004830","volume":"2022","author":"B Jiang","year":"2022","unstructured":"Jiang B, et al. Database mining detected a Cuproptosis-Related prognostic signature and a related regulatory axis in breast cancer. Dis Markers. 2022;2022:p9004830.","journal-title":"Dis Markers"},{"key":"2434_CR219","doi-asserted-by":"crossref","unstructured":"Yu L et al. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis. Genetics Research, 2023. 2023: p. 6782732.","DOI":"10.1155\/2023\/6782732"},{"issue":"10","key":"2434_CR220","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.7150\/thno.97755","volume":"14","author":"EH Kim","year":"2024","unstructured":"Kim EH, et al. Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting Immunogenic cell death. Theranostics. 2024;14(10):3777\u201392.","journal-title":"Theranostics"},{"issue":"1","key":"2434_CR221","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41420-021-00410-6","volume":"7","author":"L Fang","year":"2021","unstructured":"Fang L, et al. PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-\u03baB\/IL8 pathway. Cell Death Discovery. 2021;7(1):32.","journal-title":"Cell Death Discovery"},{"issue":"1","key":"2434_CR222","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10238-024-01491-0","volume":"24","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, et al. LncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer. Clin Experimental Med. 2024;24(1):226.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"2434_CR223","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12885-025-13661-8","volume":"25","author":"H Chen","year":"2025","unstructured":"Chen H, et al. The Hippo pathway promotes platinum-based chemotherapy by inhibiting MTF1-dependent heavy metal response. BMC Cancer. 2025;25(1):223.","journal-title":"BMC Cancer"},{"key":"2434_CR224","doi-asserted-by":"publisher","first-page":"1218276","DOI":"10.3389\/fgene.2023.1218276","volume":"14","author":"F Ge","year":"2023","unstructured":"Ge F, et al. Computational analysis of heat shock proteins and ferroptosis-associated LncRNAs to predict prognosis in acute myeloid leukemia patients. Front Genet. 2023;14:1218276.","journal-title":"Front Genet"},{"key":"2434_CR225","doi-asserted-by":"publisher","first-page":"867034","DOI":"10.3389\/fnins.2022.867034","volume":"16","author":"S Waissbluth","year":"2022","unstructured":"Waissbluth S, et al. Supporting cells and their potential roles in Cisplatin-Induced ototoxicity. Front NeuroSci. 2022;16:867034.","journal-title":"Front NeuroSci"},{"key":"2434_CR226","doi-asserted-by":"publisher","first-page":"1115608","DOI":"10.3389\/fphar.2022.1115608","volume":"13","author":"Q-T Xu","year":"2022","unstructured":"Xu Q-T, et al. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer. Front Pharmacol. 2022;13:1115608.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2434_CR227","first-page":"875","volume":"70","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Q. A novel ferroptosis-related gene signature associated with Cuproptosis for predicting overall survival in breast cancer patients. Acta Biochim Pol. 2023;70(4):875\u201384.","journal-title":"Acta Biochim Pol"},{"key":"2434_CR228","doi-asserted-by":"publisher","first-page":"1056000","DOI":"10.3389\/fgene.2023.1056000","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen X, et al. An integrative analysis revealing cuproptosis-related LncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. Front Genet. 2023;14:1056000.","journal-title":"Front Genet"},{"key":"2434_CR229","doi-asserted-by":"crossref","unstructured":"Yang W, et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159:114301.","DOI":"10.1016\/j.biopha.2023.114301"},{"issue":"11","key":"2434_CR230","first-page":"5590","volume":"13","author":"B Quan","year":"2023","unstructured":"Quan B, et al. LINC02362\/hsa-miR-18a-5p\/FDX1 axis suppresses proliferation and drives Cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res. 2023;13(11):5590\u2013609.","journal-title":"Am J Cancer Res"},{"issue":"23","key":"2434_CR231","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1111\/jcmm.17603","volume":"26","author":"L Wang","year":"2022","unstructured":"Wang L, et al. Identification of cuproptosis-related LncRNAs for prognosis and immunotherapy in glioma. J Cell Mol Med. 2022;26(23):5820\u201331.","journal-title":"J Cell Mol Med"},{"key":"2434_CR232","doi-asserted-by":"publisher","first-page":"p4661929","DOI":"10.1155\/2022\/4661929","volume":"2022","author":"W Jiang","year":"2022","unstructured":"Jiang W, et al. Construction of a prognostic model based on Cuproptosis-Related LncRNA signatures in pancreatic cancer. Can J Gastroenterol Hepatol. 2022;2022:p4661929.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2434_CR233","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard S, et al. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules. 2021;11(11):1665.","DOI":"10.3390\/biom11111665"},{"key":"2434_CR234","doi-asserted-by":"crossref","unstructured":"Li J et al. POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p\/SLC7A11 axis. Epigenomics, 2024. 16(4): pp. 215\u2013231.","DOI":"10.2217\/epi-2023-0100"},{"issue":"18","key":"2434_CR235","doi-asserted-by":"publisher","first-page":"16511","DOI":"10.1007\/s00432-023-05378-7","volume":"149","author":"L Xu","year":"2023","unstructured":"Xu L, et al. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, Cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer. J Cancer Res Clin Oncol. 2023;149(18):16511\u201323.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2434_CR236","doi-asserted-by":"publisher","first-page":"1007918","DOI":"10.3389\/fonc.2022.1007918","volume":"12","author":"G Cui","year":"2022","unstructured":"Cui G, et al. Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related LncRNAs for patients with colon adenocarcinoma. Front Oncol. 2022;12:1007918.","journal-title":"Front Oncol"},{"issue":"4","key":"2434_CR237","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-18-1656","volume":"25","author":"X Chen","year":"2019","unstructured":"Chen X, et al. Long noncoding RNA LBCS inhibits Self-Renewal and chemoresistance of bladder cancer stem cells through epigenetic Silencing of SOX2. Clin Cancer Research: Official J Am Association Cancer Res. 2019;25(4):1389\u2013403.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"30","key":"2434_CR238","doi-asserted-by":"publisher","first-page":"e34230","DOI":"10.1097\/MD.0000000000034230","volume":"102","author":"D Ding","year":"2023","unstructured":"Ding D, Wang D, Qin Y. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis. Medicine. 2023;102(30):e34230.","journal-title":"Medicine"},{"key":"2434_CR239","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang P. lncRNA\u2013CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial\u2013mesenchymal transition via the Wnt\/\u03b2\u2013catenin signaling pathway. Oncology Reports, 2021. 45(5).","DOI":"10.3892\/or.2021.8027"},{"key":"2434_CR240","doi-asserted-by":"crossref","unstructured":"Zhang C, et al. Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation. Mol Cell. 2022;82(7):1297\u20131312.e8.","DOI":"10.1016\/j.molcel.2022.01.020"},{"key":"2434_CR241","doi-asserted-by":"publisher","first-page":"111394","DOI":"10.1016\/j.cbi.2025.111394","volume":"408","author":"M Markouli","year":"2025","unstructured":"Markouli M, Skouras P, Piperi C. Impact of Cuproptosis in gliomas pathogenesis with targeting options. Chemico-Biol Interact. 2025;408:111394.","journal-title":"Chemico-Biol Interact"},{"issue":"34","key":"2434_CR242","doi-asserted-by":"publisher","first-page":"e39335","DOI":"10.1097\/MD.0000000000039335","volume":"103","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Li Q, Li Y. Exploring the role of long noncoding RNAs in autophagy and Cuproptosis processes via immune pathways in head and neck squamous carcinoma: A systematic review of the literature. Medicine. 2024;103(34):e39335.","journal-title":"Medicine"},{"issue":"4","key":"2434_CR243","doi-asserted-by":"publisher","first-page":"e4072","DOI":"10.1002\/cbf.4072","volume":"42","author":"I Ahmad","year":"2024","unstructured":"Ahmad I, et al. Emerging roles of long noncoding RNA H19 in human lung cancer. Cell Biochem Funct. 2024;42(4):e4072.","journal-title":"Cell Biochem Funct"},{"issue":"49","key":"2434_CR244","doi-asserted-by":"publisher","first-page":"e31924","DOI":"10.1097\/MD.0000000000031924","volume":"101","author":"H Di","year":"2022","unstructured":"Di H, et al. A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncrnas: A review. Medicine. 2022;101(49):e31924.","journal-title":"Medicine"},{"issue":"1","key":"2434_CR245","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40246-023-00469-5","volume":"17","author":"S Liu","year":"2023","unstructured":"Liu S, et al. Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. Hum Genomics. 2023;17(1):22.","journal-title":"Hum Genomics"},{"key":"2434_CR246","doi-asserted-by":"publisher","first-page":"1146840","DOI":"10.3389\/fphar.2023.1146840","volume":"14","author":"C Ma","year":"2023","unstructured":"Ma C, et al. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma. Front Pharmacol. 2023;14:1146840.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2434_CR247","doi-asserted-by":"publisher","first-page":"761","DOI":"10.21037\/tcr-24-1085","volume":"14","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Construction and validation of a prognostic model of LncRNAs associated with RNA methylation in lung adenocarcinoma. Translational Cancer Res. 2025;14(2):761\u201377.","journal-title":"Translational Cancer Res"},{"issue":"8","key":"2434_CR248","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s12094-023-03118-4","volume":"25","author":"D Luo","year":"2023","unstructured":"Luo D, et al. Characterization of Cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia. Clin & translational oncology: official publication of the federation of Spanish oncology societies and of the National cancer Institute of Mexico. 2023;25(8):2393\u2013407.","journal-title":"Clin & translational oncology: official publication of the federation of Spanish oncology societies and of the National cancer Institute of Mexico"},{"issue":"45","key":"2434_CR249","doi-asserted-by":"publisher","first-page":"e36026","DOI":"10.1097\/MD.0000000000036026","volume":"102","author":"F Zhou","year":"2023","unstructured":"Zhou F. Prognostic value of CASC15 and LINC01600 as competitive endogenous RNAs in lung adenocarcinoma: an observational study. Medicine. 2023;102(45):e36026.","journal-title":"Medicine"},{"issue":"17","key":"2434_CR250","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-22-0791","volume":"28","author":"S Guan","year":"2022","unstructured":"Guan S, et al. FOXM1 variant contributes to gefitinib resistance via activating Wnt\/\u03b2-Catenin signal pathway in patients with Non-Small cell lung cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2022;28(17):3770\u201384.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"2434_CR251","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41065-023-00293-w","volume":"160","author":"S Yu","year":"2023","unstructured":"Yu S, et al. A cuproptosis-related LncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma. Hereditas. 2023;160(1):31.","journal-title":"Hereditas"},{"issue":"1","key":"2434_CR252","first-page":"146","volume":"39","author":"H Katifelis","year":"2025","unstructured":"Katifelis H, et al. Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease. In Vivo (Athens, Greece). 2025;39(1):146\u201351.","journal-title":"In Vivo (Athens, Greece)"},{"issue":"1","key":"2434_CR253","doi-asserted-by":"publisher","first-page":"113335","DOI":"10.1016\/j.yexcr.2022.113335","volume":"420","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. LncRNA AC026401.3 interacts with OCT1 to intensify Sorafenib and lenvatinib resistance by activating E2F2 signaling in hepatocellular carcinoma. Exp Cell Res. 2022;420(1):113335.","journal-title":"Exp Cell Res"},{"issue":"5","key":"2434_CR254","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s10528-023-10574-8","volume":"62","author":"X-Y Jiang","year":"2024","unstructured":"Jiang X-Y, et al. Cuproptosis-Associated LncRNA gene signature establishes new prognostic profile and predicts immunotherapy response in endometrial carcinoma. Biochem Genet. 2024;62(5):3439\u201366.","journal-title":"Biochem Genet"},{"issue":"1","key":"2434_CR255","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12935-024-03486-z","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen J, Wu T, Yang Y. Sialylation-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in uterine corpus endometrial carcinoma. Cancer Cell Int. 2024;24(1):314.","journal-title":"Cancer Cell Int"},{"issue":"19","key":"2434_CR256","doi-asserted-by":"publisher","first-page":"9164","DOI":"10.1073\/pnas.1903646116","volume":"116","author":"J-L Liu","year":"2019","unstructured":"Liu J-L, et al. Endometrial carcinoma May favor partial, but not complete, loss of the TGF-\u03b2 signaling pathway. Proc Natl Acad Sci USA. 2019;116(19):9164\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2434_CR257","doi-asserted-by":"crossref","unstructured":"Tu H, et al. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs. Genes (Basel). 2022;13(12):2214.","DOI":"10.3390\/genes13122214"},{"issue":"1","key":"2434_CR258","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12672-025-01969-7","volume":"16","author":"C Qu","year":"2025","unstructured":"Qu C, et al. Construction of a novel Disulfidptosis and cuproptosis-related LncRNA signature for predicting the clinical outcome and immune response in stomach adenocarcinoma. Discover Oncol. 2025;16(1):230.","journal-title":"Discover Oncol"},{"issue":"1","key":"2434_CR259","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12943-024-02131-7","volume":"23","author":"Q Yi","year":"2024","unstructured":"Yi Q, et al. CircRNA and lncRNA-encoded peptide in diseases, an update review. Mol Cancer. 2024;23(1):214.","journal-title":"Mol Cancer"},{"issue":"1","key":"2434_CR260","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","volume":"8","author":"D Niu","year":"2023","unstructured":"Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Therapy. 2023;8(1):341.","journal-title":"Signal Transduct Target Therapy"},{"key":"2434_CR261","doi-asserted-by":"crossref","unstructured":"Liao Q, et al. p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis. Mol Cell. 2025;85(1):132\u2013149.e7.","DOI":"10.1016\/j.molcel.2024.11.013"},{"issue":"1","key":"2434_CR262","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-024-02972-6","volume":"43","author":"X Wang","year":"2024","unstructured":"Wang X, et al. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating Cuproptosis. J Experimental Clin Cancer Research: CR. 2024;43(1):68.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"1","key":"2434_CR263","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-025-03365-z","volume":"44","author":"H Xu","year":"2025","unstructured":"Xu H, et al. o8G-modified circKIAA1797 promotes lung cancer development by inhibiting Cuproptosis. J Experimental Clin Cancer Research: CR. 2025;44(1):110.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"2434_CR264","doi-asserted-by":"publisher","first-page":"1090596","DOI":"10.3389\/fimmu.2023.1090596","volume":"14","author":"B Chang","year":"2023","unstructured":"Chang B, et al. Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress. Front Immunol. 2023;14:1090596.","journal-title":"Front Immunol"},{"issue":"1","key":"2434_CR265","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12964-024-01743-2","volume":"22","author":"R Zhao","year":"2024","unstructured":"Zhao R, et al. Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy? Cell Communication Signaling: CCS. 2024;22(1):379.","journal-title":"Cell Communication Signaling: CCS"},{"issue":"5","key":"2434_CR266","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00018-022-04247-9","volume":"79","author":"H Fu","year":"2022","unstructured":"Fu H, et al. CircACTR2 in macrophages promotes renal fibrosis by activating macrophage inflammation and epithelial-mesenchymal transition of renal tubular epithelial cells. Cell Mol Life Sci. 2022;79(5):253.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2434_CR267","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, et al. EIF4A3-Induced circARHGAP29 promotes aerobic Glycolysis in Docetaxel-Resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling. Cancer Res. 2022;82(5):831\u201345.","journal-title":"Cancer Res"},{"key":"2434_CR268","doi-asserted-by":"publisher","unstructured":"Xiaowei Luan, et al. Microneedle-Loaded Gene-Editable Nanohybrids Engineer Cancer Cells by Telomere Stress Induction and Metabolic Interference for Enhanced Cuproptosis and Immunotherapy. Adv Funct Mater. 2025;35:2416285. https:\/\/doi.org\/10.1002\/adfm.202416285.","DOI":"10.1002\/adfm.202416285"},{"issue":"1","key":"2434_CR269","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. CircTTC13 promotes Sorafenib resistance in hepatocellular carcinoma through the Inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis. Mol Cancer. 2025;24(1):32.","journal-title":"Mol Cancer"},{"issue":"1","key":"2434_CR270","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40364-025-00748-4","volume":"13","author":"F Du","year":"2025","unstructured":"Du F, et al. Targeting novel regulated cell death: Disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors. Biomark Res. 2025;13(1):35.","journal-title":"Biomark Res"},{"issue":"33","key":"2434_CR271","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1038\/s41388-022-02386-8","volume":"41","author":"M-X Zhang","year":"2022","unstructured":"Zhang M-X, et al. CircME1 promotes aerobic Glycolysis and Sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1. Oncogene. 2022;41(33):3979\u201390.","journal-title":"Oncogene"},{"issue":"2","key":"2434_CR272","first-page":"1129","volume":"11","author":"M Fang","year":"2019","unstructured":"Fang M, et al. Circular RNA involved in the protective effect of Losartan on ischemia and reperfusion induced acute kidney injury in rat model. Am J Translational Res. 2019;11(2):1129\u201344.","journal-title":"Am J Translational Res"},{"key":"2434_CR273","doi-asserted-by":"crossref","unstructured":"Pan Z et al. A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy. Adv Science (Weinheim, Baden-Wurttemberg, Germany), 2022. 9(35): p. e2204513.","DOI":"10.1002\/advs.202204513"},{"issue":"4","key":"2434_CR274","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1507\/endocrj.EJ19-0271","volume":"67","author":"H Cai","year":"2020","unstructured":"Cai H, et al. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1. Endocr J. 2020;67(4):397\u2013408.","journal-title":"Endocr J"},{"issue":"12","key":"2434_CR275","doi-asserted-by":"publisher","first-page":"e2412462","DOI":"10.1002\/smll.202412462","volume":"21","author":"SS Sahoo","year":"2025","unstructured":"Sahoo SS, Manna D. Nanomaterial-Triggered ferroptosis and Cuproptosis in cancer therapy. Small. 2025;21(12):e2412462.","journal-title":"Small"},{"issue":"1","key":"2434_CR276","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12951-021-00940-2","volume":"19","author":"S Li","year":"2021","unstructured":"Li S, et al. Mesenchymal stem cell-derived extracellular vesicles prevent the development of osteoarthritis via the circHIPK3\/miR124-3p\/MYH9 axis. J of Nanobiotechnology. 2021;19(1):194.","journal-title":"J. of Nanobiotechnology"},{"issue":"8","key":"2434_CR277","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00109-024-02461-5","volume":"102","author":"Y Wu","year":"2024","unstructured":"Wu Y, et al. CircHIPK3\/miR-124 affects angiogenesis in early-onset preeclampsia via CPT1A-mediated fatty acid oxidation. J Mol Med. 2024;102(8):1037\u201349.","journal-title":"J Mol Med"},{"issue":"1","key":"2434_CR278","first-page":"23","volume":"22","author":"J Sabour Takanlu","year":"2020","unstructured":"Sabour Takanlu J, et al. Indirect tumor inhibitory effects of MicroRNA-124 through targeting EZH2 in the multiple myeloma cell line. Cell J. 2020;22(1):23\u20139.","journal-title":"Cell J"},{"key":"2434_CR279","doi-asserted-by":"publisher","first-page":"106418","DOI":"10.1016\/j.phrs.2022.106418","volume":"184","author":"M Hashemi","year":"2022","unstructured":"Hashemi M, et al. Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy. Pharmacol Res. 2022;184:106418.","journal-title":"Pharmacol Res"},{"issue":"7887","key":"2434_CR280","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-021-04071-4","volume":"600","author":"H Sun","year":"2021","unstructured":"Sun H, Hobert O. Temporal transitions in the post-mitotic nervous system of caenorhabditis elegans. Nature. 2021;600(7887):93\u20139.","journal-title":"Nature"},{"issue":"2","key":"2434_CR281","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","volume":"32","author":"M Moazzam","year":"2024","unstructured":"Moazzam M, et al. The landscape of nanoparticle-based SiRNA delivery and therapeutic development. Mol Therapy: J Am Soc Gene Therapy. 2024;32(2):284\u2013312.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"6","key":"2434_CR282","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1124\/dmd.121.000417","volume":"50","author":"JM Migliorati","year":"2022","unstructured":"Migliorati JM, et al. Absorption, distribution, metabolism, and excretion of US food and drug Administration-Approved antisense oligonucleotide drugs. Drug Metab Dispos. 2022;50(6):888\u201397.","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"2434_CR283","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122(11):1630\u20137.","journal-title":"Br J Cancer"},{"issue":"4","key":"2434_CR284","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","volume":"27","author":"E Anastasiadou","year":"2021","unstructured":"Anastasiadou E, et al. Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo. Clin Cancer Research: Official J Am Association Cancer Res. 2021;27(4):1139\u201349.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"2","key":"2434_CR285","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cac2.12254","volume":"42","author":"Z-T Yao","year":"2022","unstructured":"Yao Z-T, et al. New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Commun (London England). 2022;42(2):117\u201340.","journal-title":"Cancer Commun (London England)"},{"issue":"26","key":"2434_CR286","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1073\/pnas.1508223112","volume":"112","author":"T Hunter","year":"2015","unstructured":"Hunter T. Discovering the first tyrosine kinase. Proc Natl Acad Sci USA. 2015;112(26):7877\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2434_CR287","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/0092-8674(78)90055-7","volume":"15","author":"R Miskin","year":"1978","unstructured":"Miskin R, Easton TG, Reich E. Plasminogen activator in chick embryo muscle cells: induction of enzyme by RSV, PMA and retinoic acid. Cell. 1978;15(4):1301\u201312.","journal-title":"Cell"},{"issue":"3","key":"2434_CR288","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, et al. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25(3):211\u201332.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"2434_CR289","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2434_CR290","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40364-022-00442-9","volume":"11","author":"J Tan","year":"2023","unstructured":"Tan J, et al. Circular RNA CircEMB promotes osteosarcoma progression and metastasis by sponging miR-3184-5p and regulating EGFR expression. Biomark Res. 2023;11(1):3.","journal-title":"Biomark Res"},{"issue":"1","key":"2434_CR291","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-021-01471-y","volume":"21","author":"R Zheng","year":"2022","unstructured":"Zheng R, et al. Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3-eIF3h interaction. Mol Cancer. 2022;21(1):49.","journal-title":"Mol Cancer"},{"issue":"1","key":"2434_CR292","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/cac2.12380","volume":"43","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer. Cancer Commun (London England). 2023;43(1):100\u201322.","journal-title":"Cancer Commun (London England)"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02434-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:04:46Z","timestamp":1758809086000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02434-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":292,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02434-3","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}